Fresenius Medical Care AG
FMS23.060USD
+0.315+1.38%
Handelsschluss 01/09, 16:00（ET）Kurse um 15 Minuten verzögert
6.68BMarktkapitalisierung
16.96KGV TTM
mehr Informationen über Fresenius Medical Care AG Unternehmen
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Fresenius Medical Care AG Informationen
BörsenkürzelFMS
Name des UnternehmensFresenius Medical Care AG
IPO-datumOct 02, 1996
CEOCordola (Craig)
Anzahl der mitarbeiter111513
WertpapierartDepository Receipt
GeschäftsjahresendeOct 02
AddresseElse-Kroener-Strasse 1
StadtBAD HOMBURG VOR DER HOHE
BörseNASDAQ OMX NASDAQ Basic NYSE
LandGermany
Postleitzahl61352
Telefon4961726090
Websitehttps://www.freseniusmedicalcare.com/
BörsenkürzelFMS
IPO-datumOct 02, 1996
CEOCordola (Craig)
Führungskräfte von Fresenius Medical Care AG
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Pascale Witz
Ms. Pascale Witz
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Dominik Heger
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
--
--
Dr. Katarzyna Mazur-Hofsaess
Dr. Katarzyna Mazur-Hofsaess
Member of the Management Board, Chief Executive Officer - Care Enablement
Member of the Management Board, Chief Executive Officer - Care Enablement
--
--
Dr. Frank W. Maddux, M.D.
Dr. Frank W. Maddux, M.D.
Member of the Management Board, Global Chief Medical Officer
Member of the Management Board, Global Chief Medical Officer
--
--
Ms. Helen Giza
Ms. Helen Giza
Chairman of the Management Board, Chief Executive Officer
Chairman of the Management Board, Chief Executive Officer
--
--
Mr. A. Gregory Sorensen, M.D.
Mr. A. Gregory Sorensen, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Martin Fischer
Mr. Martin Fischer
Chief Financial Officer, Member of the Management Board
Chief Financial Officer, Member of the Management Board
--
--
Mr. Craig Cordola, Ed.D.
Mr. Craig Cordola, Ed.D.
Member of the Management Board, Chief Executive Officer - Care Delivery
Member of the Management Board, Chief Executive Officer - Care Delivery
--
--
Mr. Michael Sen
Mr. Michael Sen
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
--
Mr. Shervin J. Korangy
Mr. Shervin J. Korangy
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Pascale Witz
Ms. Pascale Witz
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Dr. Dominik Heger
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
--
--
Dr. Katarzyna Mazur-Hofsaess
Dr. Katarzyna Mazur-Hofsaess
Member of the Management Board, Chief Executive Officer - Care Enablement
Member of the Management Board, Chief Executive Officer - Care Enablement
--
--
Dr. Frank W. Maddux, M.D.
Dr. Frank W. Maddux, M.D.
Member of the Management Board, Global Chief Medical Officer
Member of the Management Board, Global Chief Medical Officer
--
--
Ms. Helen Giza
Ms. Helen Giza
Chairman of the Management Board, Chief Executive Officer
Chairman of the Management Board, Chief Executive Officer
--
--
Mr. A. Gregory Sorensen, M.D.
Mr. A. Gregory Sorensen, M.D.
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
North America
14.78B
70.68%
Rest of the world
5.61B
26.84%
Germany
518.03M
2.48%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Aktionärsstatistik
Aktualisiert: Sun, Nov 16
Aktualisiert: Sun, Nov 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Pzena Investment Management, LLC
2.56%
Wellington Management Company, LLP
1.42%
Fiduciary Management, Inc.
0.94%
Dodge & Cox
0.66%
Todd Asset Management LLC
0.22%
Andere
94.20%
Aktionäre
Aktionäre
Anteil
Pzena Investment Management, LLC
2.56%
Wellington Management Company, LLP
1.42%
Fiduciary Management, Inc.
0.94%
Dodge & Cox
0.66%
Todd Asset Management LLC
0.22%
Andere
94.20%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
5.15%
Investment Advisor
2.13%
Hedge Fund
0.35%
Research Firm
0.25%
Pension Fund
0.14%
Family Office
0.02%
Bank and Trust
0.01%
Andere
91.95%
Institutionelle Beteiligung
Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
346
46.58M
8.04%
-2.99M
2025Q3
337
47.00M
8.12%
-7.47K
2025Q2
350
47.02M
8.22%
+2.00M
2025Q1
348
45.04M
8.08%
-2.40M
2024Q4
337
43.94M
8.01%
+456.34K
2024Q3
325
43.49M
7.70%
+2.26M
2024Q2
343
41.23M
8.48%
-1.66M
2024Q1
362
42.90M
8.31%
-5.86M
2023Q4
362
42.80M
8.39%
+76.36K
2023Q3
367
42.72M
8.58%
-1.02M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Pzena Investment Management, LLC
14.82M
2.56%
+153.87K
+1.05%
Sep 30, 2025
Wellington Management Company, LLP
8.20M
1.42%
--
--
Sep 30, 2025
Fiduciary Management, Inc.
5.46M
0.94%
-198.98K
-3.52%
Sep 30, 2025
Dodge & Cox
3.83M
0.66%
--
--
Sep 30, 2025
Todd Asset Management LLC
1.30M
0.22%
+64.31K
+5.19%
Sep 30, 2025
Aristotle Capital Management, LLC
1.13M
0.2%
-7.00K
-0.61%
Sep 30, 2025
Parametric Portfolio Associates LLC
985.01K
0.17%
+12.65K
+1.30%
Sep 30, 2025
Morgan Stanley & Co. International Plc
908.00K
0.16%
-350.00K
-27.82%
Sep 30, 2025
Janus Henderson Investors
829.14K
0.14%
+300.92K
+56.97%
Jun 30, 2025
Kentucky Teachers' Retirement System
816.20K
0.14%
+62.70K
+8.32%
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Cultivar ETF
1.01%
ActivePassive International Equity ETF
0.08%
Avantis Responsible International Equity ETF
0.06%
Avantis International Equity ETF
0.01%
Pacer Developed Markets International Cash Cws 100
0%
Unusual Whales Subversive Democratic Trading ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
SGI Enhanced Global Income ETF
0%
Unusual Whales Subversive Republican Trading ETF
0%
The Opal International Dividend Income ETF
0%
Mehr Anzeigen
Cultivar ETF
Anteil1.01%
ActivePassive International Equity ETF
Anteil0.08%
Avantis Responsible International Equity ETF
Anteil0.06%
Avantis International Equity ETF
Anteil0.01%
Pacer Developed Markets International Cash Cws 100
Anteil0%
Unusual Whales Subversive Democratic Trading ETF
Anteil0%
DFA Dimensional International Core Equity 2 ETF
Anteil0%
SGI Enhanced Global Income ETF
Anteil0%
Unusual Whales Subversive Republican Trading ETF
Anteil0%
The Opal International Dividend Income ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
1.59B
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
May 07, 2025
FMS.NB Final Cash Dividend of gross USD 0.814968 paid on Jun 06, 2025 going ex on May 23, 2025
May 23, 2025
Jun 06, 2025
May 23, 2025
Apr 15, 2024
FMS.NB Final Cash Dividend of gross USD 0.642838 paid on Jun 03, 2024 going ex on May 17, 2024
May 20, 2024
Jun 03, 2024
May 17, 2024
May 03, 2023
FMS.NB Final Cash Dividend of gross USD 0.604856 paid on Jun 01, 2023 going ex on May 17, 2023
May 18, 2023
Jun 01, 2023
May 17, 2023
Apr 28, 2022
FMS.NB Final Cash Dividend of gross USD 0.708547 paid on May 27, 2022 going ex on May 13, 2022
May 16, 2022
May 27, 2022
May 13, 2022
May 16, 2021
FMS.NB Final Cash Dividend of gross USD 0.819276 paid on Jun 07, 2021 going ex on May 24, 2021
May 25, 2021
Jun 07, 2021
May 24, 2021
Aug 12, 2020
FMS.NB Final Cash Dividend of gross USD 0.71688 paid on Sep 11, 2020 going ex on Aug 28, 2020
Aug 31, 2020
Sep 11, 2020
Aug 28, 2020
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Fresenius Medical Care AG?
Die fünf größten Anteilseigner von Fresenius Medical Care AG sind:
Pzena Investment Management, LLC hält 14.82M Aktien, was 2.56% der Gesamtaktien entspricht.
Wellington Management Company, LLP hält 8.20M Aktien, was 1.42% der Gesamtaktien entspricht.
Fiduciary Management, Inc. hält 5.46M Aktien, was 0.94% der Gesamtaktien entspricht.
Dodge & Cox hält 3.83M Aktien, was 0.66% der Gesamtaktien entspricht.
Todd Asset Management LLC hält 1.30M Aktien, was 0.22% der Gesamtaktien entspricht.
Pzena Investment Management, LLC hält 14.82M Aktien, was 2.56% der Gesamtaktien entspricht.
Wellington Management Company, LLP hält 8.20M Aktien, was 1.42% der Gesamtaktien entspricht.
Fiduciary Management, Inc. hält 5.46M Aktien, was 0.94% der Gesamtaktien entspricht.
Dodge & Cox hält 3.83M Aktien, was 0.66% der Gesamtaktien entspricht.
Todd Asset Management LLC hält 1.30M Aktien, was 0.22% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von Fresenius Medical Care AG?
Die drei wichtigsten Anteilseigner-Typen von Fresenius Medical Care AG sind:
Pzena Investment Management, LLC
Wellington Management Company, LLP
Fiduciary Management, Inc.
Pzena Investment Management, LLC
Wellington Management Company, LLP
Fiduciary Management, Inc.
Wie viele Institutionen halten Anteile an Fresenius Medical Care AG (FMS)?
Mit Stand vom 2025Q4 halten 346 Institutionen Anteile an Fresenius Medical Care AG, mit einem Gesamtmarktwert von etwa 46.58M, was 8.04% der Gesamtanteile entspricht. Im Vergleich zum 2025Q3 ist der institutionelle Aktienbesitz um -0.08% gestiegen.
Was ist die größte Einnahmequelle von Fresenius Medical Care AG?
Am FY2024 erzielte das Geschäft mit -- für Fresenius Medical Care AG den höchsten Umsatz in Höhe von --, was --% des Gesamtumsatzes entspricht.
